Quantcast

Latest Clinical trial Stories

2014-08-24 23:02:07

MarketOptimizer.org adds “Trigeminal Neuralgia Global Clinical Trials Review, H2, 2014” to its store. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Dallas, Texas (PRWEB) August 24, 2014 Clinical trial report, “Trigeminal Neuralgia Global Clinical Trials Review, H2, 2014″ provides data on the Trigeminal Neuralgia clinical trial scenario. This report provides elemental information and data relating to...

2014-08-23 23:01:03

MarketOptimizer.org adds “Cardiomyopathy Global Clinical Trials Review, H2, 2014” to its store. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Dallas, Texas (PRWEB) August 23, 2014 Cardiomyopathy (heart muscle disease) is the measurable deterioration of the function of the myocardium (the heart muscle) for any reason, usually leading to heart failure; common symptoms are dyspnea (breathlessness) and...

2014-08-21 20:22:34

LYNBROOK, N.Y., Aug. 21, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX(®) in the EU, today announced positive, statistically significant results from a randomized, double-blind Phase 2a study of CCH for the potential treatment of cellulite, or edematous fibrosclerotic panniculopathy. The results...

2014-08-21 08:29:22

Patient recruitment-retention leader MediciGlobal expands its international team as the company continues to invest in best in class talent PHILADELPHIA and LONDON, Aug. 21, 2014 /PRNewswire/ -- MediciGlobal Ltd., a global leader in patient recruitment and retention for clinical trials, today announced the appointment of Linda Capsey, PhD as Vice President Project Management and Innovation. With more than 20 years industry experience, Dr. Capsey joins MediciGlobal's dynamic...

2014-08-21 08:29:20

PHILADELPHIA, Aug. 21, 2014 /PRNewswire/ -- ACI Clinical (www.aciclinical.com) announces a new, standards-based platform for independent Data Monitoring Committees. http://photos.prnewswire.com/prnvar/20131120/PH19940LOGO Using this solution, trial sponsors can save up to 30 percent over industry standard costs and receive the same expertise that has made ACI an industry leader in committee services. Leveraging a decade of DMC experience (initial design, member recruitment and...

2014-08-21 08:28:33

ENGLEWOOD, Colo., Aug. 21, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a delay in the data analysis of the STEP Study due to the discovery by the independent Clinical Research Organization (CRO) that the study drug (both Ampion(TM) and the placebo) were, during shipment to the clinical sites, exposed to lower temperatures than permitted by the drug specifications. http://photos.prnewswire.com/prnvar/20120516/MM09116LOGO Michael Macaluso, Ampio's...

2014-08-21 08:28:27

Mid and High Level Doses Demonstrate Statistically Significant Improvement in Cellulite Across All Endpoints; Nearly 70% of Mid and High Dose Patients Satisfied or Very Satisfied with Results CHESTERBROOK, Pa., Aug. 21, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced positive results from a randomized, double-blind Phase 2a study of collagenase clostridium histolyticum (or CCH) for the treatment of edematous...

2014-08-20 08:27:41

ENGLEWOOD, Colo., Aug. 20, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that in response to requests from patients and physicians, the company has performed an analysis of the available data from both portions of the study. On October 7, 2013, following an IDRC determination "that there was a treatment dosage (of Optina(TM)) that was demonstrating a potentially beneficial anatomic effect." The company initiated an open label extension study using the...

2014-08-19 23:13:32

With more than 50 years of combined experience, expert presenters Sherri Hubby and Brian Nugent will share insights that can be used to establish Risk Based Monitoring Plans, including triggers for return to 100% source data verification. Even better, they'll show attendees how to proactively identify and manage risks to trials with methods that can immediately be implemented and used. Falls Church, VA (PRWEB) August 19, 2014 Managing Risk for Clinical Trials: Incorporating Quality by...

2014-08-19 16:29:08

Funding To Increase Manufacturing Capacity for Ramp-Up of Programs BETHESDA, Md., Aug. 19, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the $17.5 million convertible note offering announced last Thursday, August 14, 2014, has closed. The three-year notes have a 5% interest rate and are convertible at $7.30 per share of common stock. The...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.